 | Up a level |
2021
Oezkan, Filiz, Eisenmann, Stephan 
ORCID: 0000-0002-0387-0760, Darwiche, Kaid, Gassa, Asmae, Carbone, David P., Merritt, Robert E. and Kneuertz, Peter J.
(2021).
Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics-A Technical Review.
J. Clin. Med., 10 (23).
BASEL:
MDPI.
ISSN 2077-0383
2019
Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent ORCID: 0000-0002-5807-9503, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Juergen, Govindan, Ramaswamy and Carbone, David P.
(2019).
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study.
Clin. Cancer Res., 25 (23).
S. 6958 - 6967.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265
2018
Drilon, Alexander, Lin, Jessica J., Filleron, Thomas, Ni, Ai ORCID: 0000-0003-3002-3556, Milia, Julie, Bergagnini, Isabella, Hatzoglou, Vaios, Velcheti, Vamsidhar, Offin, Michael, Li, Bob, Carbone, David P., Besse, Benjamin ORCID: 0000-0001-5090-8189, Mok, Tony, Awad, Mark M., Wolf, Jurgen, Owen, Dwight ORCID: 0000-0002-6598-4886, Camidge, D. Ross, Riely, Gregory J., Peled, Nir, Kris, Mark G., Mazieres, Julien, Gainor, Justin F. and Gautschi, Oliver
(2018).
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.
J. Thorac. Oncol., 13 (10).
S. 1595 - 1602.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
2017
Drilon, Alexander E., Filleron, Thomas, Bergagnini, Isabella, Milia, Julie, Hatzoglou, Vaios, Velcheti, Vamsidhar, Besse, Benjamin ORCID: 0000-0001-5090-8189, Mok, Tony, Awad, Mark M., Wolf, Juergen, Carbone, David P., Camidge, D. Ross, Riely, Gregory J., Peled, Nir, Mazieres, Julien, Kris, Mark G. and Gautschi, Oliver
(2017).
Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers.
J. Clin. Oncol., 35.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Gautschi, Oliver, Milia, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David P., Owen, Dwight ORCID: 0000-0002-6598-4886, Camidge, Ross, Narayanan, Vignhesh, Doebele, Robert C. ORCID: 0000-0001-6728-6857, Besse, Benjamin ORCID: 0000-0001-5090-8189, Remon-Masip, Jordi, Janne, Pasi A., Awad, Mark M., Peled, Nir, Byoung, Chul-Cho, Karp, Daniel D., Van Den Heuvel, Michael, Wakelee, Heather A., Neal, Joel W., Mok, Tony S. K., Yang, James C. H., Ou, Sai-Hong Ignatius, Pall, Georg, Froesch, Patrizia, Zalcman, Gerard, Gandara, David R., Riess, JonathanW., Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Frueh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay ORCID: 0000-0003-2087-4963, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha I., Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian ORCID: 0000-0001-7204-5652, Mazieres, Julien and Drilon, Alexander
(2017).
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
J. Clin. Oncol., 35 (13).
S. 1403 - 1414.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755